We report a pediatric patient with xeroderma pigmentosum (XP) who developed hemophagocytic lymphohistiocytosis (HLH) secondary to Brucella infection—an exceedingly rare occurrence. XP is a rare autosomal recessive genetic disorder characterized by extreme ultraviolet radiation (UVR) sensitivity due to the inability to repair DNA pyrimidine dimers caused by UV exposure. This defect leads to a markedly increased risk of skin cancer and progressive neurological degeneration (Leung, 2022). HLH is a rare, potentially fatal hypersensitivity syndrome characterized by excessive activation and impaired downregulation of T‐lymphocytes and macrophages. This dysregulation results in an overproduction of proinflammatory cytokines, destruction of blood cells, and subsequent tissue and organ damage (Fisman, 2000). While secondary HLH may follow various infections, Brucella‐induced HLH is rare (Wolska, 2006), and to our knowledge, this is the first reported case in a patient with XP.
5 September 2025 in Surgical Neurology International
Background: Spinal myxopapillary ependymomas (MPEs) are a rare subtype of ependymomas that typically arise in the conus medullaris, cauda equina, and filum terminale, most commonly affecting adults aged 30–50 years and usually located in the lumbosacral spine. Anaplastic MPEs are an even rarer, more aggressive variant that often present at a younger age than conventional MPEs. Case Description: We report a 20-month-old male who presented with a two-week history of abnormal gait and neck stiffness and was diagnosed with anaplastic MPE. Conclusion: This case adds to the limited pediatric literature on anaplastic MPE and underscores the importance of early recognition, thorough histopathological evaluation, and long-term follow-up.
Gray platelet syndrome (GPS) is a rare inherited platelet disorder characterized by the presence of gray platelets on blood smears, resulting from a deficiency of α ‐granules. The thrombocytopenia presents in a spectrum of bleeding tendencies, varying among different patients. We present a case of a 14‐year‐old male presenting with recurrent epistaxis, thrombocytopenia, hepatosplenomegaly, and recurrent infections that had not been diagnosed previously. Whole‐exome gene sequencing revealed a homozygous likely pathogenic splice‐site variant in the NBEAL2 gene, confirming the diagnosis of GPS, which is inherited in an autosomal recessive manner due to biallelic variants in NBEAL2. The patient had atypical hepatomegaly and low lymphocyte and monocyte counts, findings consistent with emerging evidence that GPS affects multiple hematopoietic lineages. It also contributes to immune dysregulation and results in increased susceptibility to autoimmune disorders, highlighting the need for guidelines to screen for autoimmune complications in GPS patients.
Background: Bruck syndrome is a rare autosomal recessive disorder characterized by osteogenesis imperfecta–like bone fragility and congenital joint contractures. Clinical overlap with other connective tissue disorders makes early diagnosis challenging, and genetic testing remains essential. Case Presentation: We describe an 18‐month‐old female with a homozygous PLOD2 pathogenic variant confirming Bruck syndrome Type 2. She presented at 5 weeks with congenital joint contractures and right developmental dysplasia of the hip. Her course included successful surgical correction of hip dislocation and improvement in limb function with physiotherapy, allowing independent ambulation. Family segregation analysis identified both parents as carriers, enabling accurate recurrence‐risk counseling. Conclusion: Early genetic confirmation and coordinated multidisciplinary care support better functional outcomes in Bruck syndrome. Additional case reporting is needed to strengthen the understanding of phenotype variability and guide management.
1 January 2026 in Case Reports in Infectious Diseases
Background: Disseminated mucormycosis is a rare, angioinvasive fungal infection predominantly affecting immunocompromised individuals, especially those with poorly controlled diabetes. Case Presentation: A 57‐year‐old Palestinian woman presented with sudden unilateral blindness, ophthalmoplegia, facial numbness, and ptosis, with hyperglycemia. Early brain MRI/MRA/MRV findings were normal, suggesting that giant cell arteritis, or other autoimmune vasculitis, was suspected; thus, IV steroids were administered. Subsequently, her condition progressed to bilateral fixed pupils, complete ophthalmoplegia, and palatal black necrosis. Subsequent imaging and sinus biopsy confirmed disseminated mucormycosis. Treatment included intravenous Amphotericin B, anticoagulation, functional endoscopic sinus surgery, and later left eye enucleation. Despite maximal therapy, she developed a large hemorrhagic venous infarction and ultimately died. Conclusions: Mucormycosis can initially mimic autoimmune or vascular neuro‐ophthalmic disease and may present with normal imaging. In acute vision loss with hyperglycemia, maintaining early suspicion and avoiding corticosteroids until fungal infection is excluded are essential to prevent rapid, fatal progression.
Behçet's disease is a systemic inflammatory vasculitis that can involve vessels of any size, with pulmonary artery aneurysms representing a rare but potentially fatal complication. Hemoptysis is the most common presentation and may recur despite medical or interventional therapy. We report a 38‐year‐old man with Behçet's disease and a history of right pulmonary artery aneurysm treated with endovascular coil embolization and ongoing immunosuppressive therapy, who presented with recurrent hemoptysis. He was managed with supportive care, high‐dose corticosteroid pulse therapy, and continuation of biologic immunosuppressants. Hemoptysis resolved, and follow‐up imaging was planned to monitor disease progression. Pulmonary artery involvement in BD demands a patient‐specific, integrated management strategy combining medical therapy, interventional procedures, and careful monitoring to prevent fatal complications and ensure long‐term disease control.